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Abstract  
 
Cells are constantly exposed to sources of oxidative stress. If left unrepaired, the 
oxidative modification of DNA can result in a loss of genome integrity and may lead to 
diseases including cancer. The most common form of oxidative DNA damage is the 
oxidation of the DNA base guanine to the highly mutagenic 8-oxo-7,8-dihydro-guanine 
(8-oxoG).  To protect the genome from mutagenesis, the modified base is removed 
through the process of Base Excision Repair (BER).  
 
Single stranded DNA binding proteins (SSBs) are a family of proteins that act to protect 
the genome from mutagenesis by recognizing and binding to sites of DNA damage, 
where the DNA is unwound into its single strands. Human Single Stranded DNA 
binding protein 1 (hSSB1), a novel human SSB, is crucial in the removal of 8-oxoG 
from the genome through the BER pathway. Previous research has found that the 
ability of hSSB1 to form dimers, tetramers and higher aggregates (through the 
formation of disulfide bonds at the C81 and C99 residues) under oxidative conditions 
is critical in its function in BER.  
 
This thesis examines the molecular details of hSSB1 oligomerisation in response to 
oxidative DNA damage and the mechanism by which the hSSB1 oligomer binds DNA. 
In this work Nuclear Magnetic Resonance (NMR) spectroscopy and Surface Plasmon 
Resonance (SPR) experiments are used to determine how oligomeric hSSB1 binds 
ssDNA and ssDNA incorporating 8-oxoG bases. The findings reveal that binding of 
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non-reduced hSSB1 to 8-oxoG ssDNA is indistinguishable to its binding to unmodified 
ssDNA, indicating no change in the underlying mechanism. Further, using SPR I show 
that non-reduced hSSB1 binds more strongly to ssDNA than reduced protein 
confirming that hSSB1 oligomers recognise ssDNA with a tighter binding affinity. To 
determine the structural basis of these oligomeric hSSB1-ssDNA interactions 2D 1H-
15N HSQC NMR titrations were carried out with ssDNA oligos of varying length. The 
data reveal that ssDNA binding takes place via hSSB1 tetramers that are structurally 
identical to the ones that were previously described in the absence of ssDNA and 
suggests that hSSB1 binds DNA bi-directionally. Additionally, using 2D 1H-15N HSQC 
NMR and 2D 1H-1H NOESY NMR experiments, I show that the hSSB1 oligomer 
unwinds damaged dsDNA and binds to its single strands.   
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1. Introduction  
 
1.1 Oxidative DNA damage  
 
Cells are subject to constant oxidative stress that can damage the integrity of the 
genome and lead to diseases including cancer (1, 2). The major source of oxidative 
stress in eukaryotic cells is reactive oxygen species (ROS) which are generated as by-
products of endogenous metabolism or produced as a result of exogenous stresses 
such as ionizing radiation and ultraviolet (UV) light (3). ROS readily react with lipids, 
proteins and nucleic acids and act to oxidatively modify them (4). While lipids and 
proteins that have been modified can be broken down and resynthesised, damage to 
DNA must be repaired before replication and cell division occur (5), as  the changes to 
DNA base stacking and hydrogen bonding of DNA caused by oxidative modification 
compromise the expression and replication of genetic information.  
 
Guanine, due to its chemical structure and low redox potential, is the most commonly 
modified DNA base (6).The oxidation of guanine by ROS results in the formation of 8-
oxo-7,8-dihydro-guanine (8-oxoG) (Fig 1 A) (7). There are four forms of 8-oxoG found 
in solution, the most prevalent of which (under physiological conditions) contains a 
carbonyl group on C8 and protonated N7 (8-10). This altered arrangement of hydrogen 
bond donors and acceptors mean that additional to Watson-Crick pairing with cytosine, 
8-oxoG has the ability to form stable Hoogsteen pairs with adenine (Fig 1 B).  
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Figure 1. Basis of the mutagenic transversion caused by 8-oxoguanine. A) Oxidation of guanine 
to 8-oxoguanine by reactive oxygen species (ROS). B) Hoogsteen pairing between 8-oxoguanine 
and adenine displaying the location of potential hydrogen bond formation (blue dashed line). 
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As 8-oxoG can pair with adenine as well as cytosine, a G:C to A:T transversion may 
occur during replication as a result of the base modification (11). The accumulation of 
8-oxoG in the genome is mutagenic, and the removal of 8-oxoG is crucial in 
maintaining genomic stability (12, 13). The repair of 8-oxoG has been extensively 
studied due to the mutagenic potential of the modification, as well as its role as a 
biomarker for oxidative DNA damage (4).   
 
1.2 Base Excision Repair  
 
To combat the deleterious effects of DNA damage, organisms from Escherichia coli to 
mammals have evolved repair mechanisms such as Base Excision Repair (BER) to 
recognize, remove and replace DNA modifications (13, 14). BER is the main 
mechanism responsible for preventing the build-up of 8-oxoG in the human genome 
(15). 
 
The BER process, as it is currently understood, can be broken down into 5 steps (Fig 
2) (13, 16):   
1. Excision of damaged base  
2. Incision of resulting abasic site  
3. Replacement of excised nucleotide with correct nucleotide  
4. Clean up of terminal ends  
5. Nick ligation  
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Figure 2. Removal of 8-oxoG through Base Excision Repair. Excision of damaged base by human 
oxoguanine glycosylase 1 (hOGG1), incision of the resulting abasic site by the 
apurinic/apyrimidinic (AP) endonuclease activity of hOGG1, replacement of correct nucleotide 
by DNA polymerase β and ligation of nick by DNA ligase III. 
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Glycosylases are responsible for the initial recognition phase of BER and the removal 
of the mutagenic base modification 8-oxoG in humans is initiated by Human 
Oxoguanine Glycosylase 1 (hOGG1) (17, 18). hOGG1 is an enzyme that possesses 
two catalytic activities (19).   
 
The hOGG1 enzyme first acts as a DNA glycosylase, cleaving the N-glycosidic bond, 
then functions as an apurinic/apyrimidinic (AP) nuclease, removing the 3’ phosphate 
of the resultant abasic site (20). DNA polymerase beta (POLβ) replaces the removed 
8-oxoG base with a guanine residue that is ligated in place by the action of DNA ligase 
III (21). 
 
1.3 Single Stranded DNA Binding Proteins   
 
Recent studies have found that a novel human single stranded DNA binding protein 
plays a role in hOGG1 localization to sites of oxidative damage in humans (22). Single 
stranded DNA binding proteins (SSBs) are a family of proteins that play an essential 
role in the repair of damaged DNA (23). The double stranded, helical structure of DNA 
affords the genome a degree of protection. However, regular cellular processes such 
as DNA replication and repair, as well as DNA damaging events (see previous 
sections) can expose single stranded DNA (ssDNA), and therefore the genetic code, 
to damage. SSBs act to protect ssDNA from degradation, function in the detection of 
DNA damage,  and play a role in the recruitment of repair proteins to sites of DNA 
damage (24).  
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SSBs are found in organisms from all three domains of life. There are two types of 
SSBs- simple and complex. Simple SSBs contain a single 
oligonucleotide/oligosaccharide binding (OB) fold while complex SSBs have multiple 
OB domains. The structure of these OB domains is highly conserved (Fig 3). The 
number and sequence of amino acids (AAs) present in OB folds varies between 
proteins, however, there are a number of structural features that are common to all OB 
folds. OB folds from all three domains of life contain five antiparallel β strands, coiled 
to form a barrel structure which is capped by an α helix (between the 3rd and 4th β 
strands) on one end, and contains a DNA binding cleft on the other (25). 
 
 
Figure 3. Single stranded DNA binding protein (SSB) oligonucleotide/oligosaccharide binding 
(OB) domain crystal structures from all three domains of life. SSB OB domain of A) Sulfolobus 
solfactaricus (PDB ID 1O7I), B) Escherichia coli (PDB ID 1SRU) and C) Human replication protein 
A (PDB ID 1JMC). 
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SSBs that have been extensively studied include E. coli SSB (EcoSSB), a simple SSB 
that oligomerises to form a functional homotetramer with 4 OB domains (26, 27). 
Sulfolobus solfactaricus SSB (SsoSSB) a monomer with one OB domain, and 
Replication Protein A (RPA), a complex SSB which forms a heterotrimeric protein 
composed of 6 OB domains, from three RPA proteins: - RPA70, RPA34 and RPA14 
(Fig 4) (28-30).  
 
Figure 4. Domain organisation of singe stranded DNA binding proteins (SSBs) from all three 
domains of life - Bacteria (Escherichia coli), Archaea (Sulfolobus solfactaricus), and Eukarya 
(human replication protein A and single stranded DNA binding protein 1).  
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1.4 Human Single Stranded DNA Binding Protein 1  
 
Human single stranded DNA binding protein 1 (hSSB1) is a member of the SSB protein 
family that is known to have a crucial role in the maintenance of genomic stability (31, 
32). One of two simple human SSBs, hSSB1 has previously been found to function in 
double stranded break (DSB) repair, forming a part of the MRN complex as well as the 
SOSS1 protein complex with INTS3 and another small protein C9orf80 (33-35). More 
recent studies have found that hSSB1 is also involved in the removal of 8-oxoG from 
the genome, playing a central role in the recruitment of hOGG1 to damaged chromatin 
after oxidative damage (Fig 5) (22).  
  
Previous research (analytical SEC in combination with MALLS) has determined that 
while reduced hSSB1 is a functional monomer, non-reduced hSSB1 forms dimers, 
tetramers and higher-order oligomers (36). The hSSB1 monomer contains a single, 
highly conserved OB fold at the N-terminus followed by a flexible, spacer region and a 
conserved C-terminal tail that is involved in protein-protein interactions (37, 38). The 
structure of full length hSSB1 (1–211) was first solved in complex with INTS3 as a part 
of the SOSS1 complex (38). The published X-ray crystal structure of this complex (PDB 
ID 4OWX) demonstrated that residues 5–109 of hSSB1 form a typical OB fold 
composed five anti-parallel β strands (β1, β3, β4, β5 and β6), capped by an α helix 
(α1) between β3 and β4. 
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Figure 5. hSSB1 is required for the localisation of human oxoguanine glycosylase 1 (hOGG1) to 
sites of oxidative damage A) hSSB1 localises to chromatin after oxidative damage. B) hOGG1 
does not localise to chromatin in the absence of hSSB1. Immunofluorescence of hSSB1 (green), 
hOGG1 (red) and DAPI (blue) in pre-permeabilized, detergent washed and fixed U2OS cells 
treated with 250 µM H2O2 for 30 min (see ref (22)). 
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Three cysteine residues are present in the OB fold of hSSB1, two of which are solvent 
exposed (C81 and C99) (39). These cysteine residues facilitate the oligomerisation of 
hSSB1 under oxidative conditions, where hSSB1 oligomerises to form homo-dimers 
and homo-tetramers (40). In addition to C81 and C99, Nuclear Magnetic Resonance 
(NMR) experiments have revealed a set of charged and polar residues (N16, N18, 
K33, T71, K72, R88 and D91) within the OB domain of hSSB1 that are also involved 
in oligomer formation (36). These residues, along with C81 and C99, were found to be 
located on two distinct sides of the hSSB1 protein. 
 
A molecular model describing the structural details of this oligomerisation process has 
been calculated (36) (Fig 6), informed by mutational data and the tetrameric structure 
of EcoSSB (PDB 1SRU) (26, 36, 41, 42). This model of self-oligomerisation proposes 
that hSSB1 can exist as a functional tetramer, with monomer-monomer and dimer-
dimer interactions occurring at distinct surfaces of the OB domain. The structure of the 
tetramer suggests that hSSB1 oligomerisation does not preclude interaction with either 
the SOSS1 or MRN complex. Further, the interface for hSSB1-hSSB1 interaction does 
not overlap with the ssDNA binding surface.  
 
Interaction between hSSB1 and ssDNA is facilitated by residues 2-16 which form a 
DNA binding groove at the N-terminus, as well as loops β2-β3 and β4-α1B and strands 
β4, β5, and β6.  DNA binding is mediated by electrostatic interaction, hydrogen bonding 
and base-stacking involving residues T32, K33, W55, D56, Y74, F78, Y85 and R88. 
Base stacking is modulated by four aromatics (W55, Y74, F78 and Y85), similar to the 
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structurally homologous SsoSSB (43). Similar to other members of the SSB family,  
hSSB1 has a preference for binding to pyrimidine-rich sequences (31) and the crystal 
structure of the hSSB1-DNA binding interface (PDB ID 4OWX) indicates that hSSB1 
(as a monomer) has the ability to intercalate with 6 DNA bases of a poly-thymine DNA 
sequence (38).  
 
 
 
 
Figure 6. Model of hSSB1 self-oligomerisation (Figshare data repository, DOI: 
10.6084/m9.figshare.3422788) (36). A) Four monomers (I, II, III and IV) in tetramer formation 
facilitated by disulphide bonds (yellow). B) Interface of monomers I and II with residues involved 
in monomer-monomer interaction through the formation of hydrogen and electrostatic bonds 
(sticks) (C) Interface of dimers I/II and III/IV displaying residues involved in dimer-dimer 
interaction (sticks). 
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The formation of the hSSB1 oligomer following oxidative stress is vital for hSSB1 to 
efficiently function in the removal and repair of 8-oxoG (39, 40). However, the 
molecular details of how hSSB1 dimers and tetramers recognise DNA as well as the 
differences in the binding affinity between monomeric and oligomeric hSSB1 are yet to 
be determined (22). 
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2. Materials and Methods  
 
2.1 Reagents, Equipment and Buffers  
 
Table 2.1.1 Chemicals and reagents  
 
Chemicals and Reagents  Supplier  
2 log ladder  New England BioLabs (Beverly, MA, 
USA)  
2,2-dimethyl-2-silapentane-5-sulfonic 
acid (DSS)  
Sigma (Castle Hill, NSW)  
Agarose  Progen (Darra, QLD)  
Ampicillin (AMP)  GoldBio Inc. (Olivette, MO, USA)  
Bacteriological agar  Amyl Media (Kings Langley, NSW)  
BamH1  New England BioLabs (Beverly, MA, 
USA)  
BIAcoreTM sensor chip – Streptavidin (SA)  BIAcoreTM Life Sciences, GE Healthcare 
(Rydalmere, NSW)  
BIAcoreTM Surfactant p20  BIAcoreTM Life Sciences, GE Healthcare 
(Rydalmere, NSW)  
Casein peptone  Oxoid Ltd. (Hampshire, England)  
Deuterium oxide (D2O)  Sigma (Castle Hill, NSW)  
Dithiothretiol (DTT)  GoldBio Inc. (Olivette, MO, USA)  
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DNA oligonucleotides  Sigma (Castle Hill, NSW)  
DNase I  Sigma (Castle Hill, NSW)  
EcoR1 New England BioLabs (Beverly, MA, 
USA) 
Glutathione Sepharose 4B  GE Healthcare (Rydalmere, NSW)  
Human Rhinovirus (HRV) 3C protease  Produced in-house  
Isolate II PCR and gel kit  Bioline (Eveleigh, NSW)  
Isolate II Plasmid mini kit  Bioline (Eveleigh, NSW)  
Isopropyl β-D-1-thiogalactopyranoside 
(IPTG) 
GoldBio Inc. (Olivette, MO, USA)  
Mark12TM protein standards  Invitrogen (Mount Waverley, VIC)  
MilliQ Water (MQW)  Millipore (Billerica, MA, USA)  
NuPage Novex 4-12% Bis-Tris Mini 
precast gels  
Invitrogen (Mount Waverley, VIC)  
Phenylmethylsulfonyl fluoride (PMSF)  GoldBio Inc. (Olivette, MO, USA)  
Qiagen gel extraction kit  Qiagen (Clifton Hill, VIC)  
Sodium chloride  Sigma (Castle Hill, NSW)  
Tris(2-carboxyethyl)phosphine 
hydrochloride (TCEP-HCL)  
GoldBio Inc. (Olivette, MO, USA)  
Triton X-100  Sigma (Castle Hill, NSW)  
Yeast extract  Oxoid Ltd. (Hampshire, England)  
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Table 2.1.2 Equipment 
 
Equipment  Supplier  
BIAcore 2000   (BIAcore AB, Uppsala, Sweden) 
Biologic Fast Performance Liquid 
Chromatography (FPLC) System  
Bio-Rad (Hemel Hempstead, UK)  
Bruker AvanceTM 600  Bruker (Billerica, MA, USA)  
Bruker AvanceTM 800  Bruker (Billerica, MA, USA)  
HiLoadTM 16/60 SuperdexTM 75 
preparative grade column  
GE Healthcare (Piscataway, NJ, USA)  
HiTrap Heparin high performance 5 
ml column  
GE healthcare (Piscataway, NJ, USA)  
Nanodrop 2000 Spectrophotometer  ThermoScientific (Waltham, MA, USA)  
NGC chromatography system  Bio-Rad (Hemel Hempstead, UK) 
Orbital shaker incubator  ThermoScientific (Waltham, MA, USA)  
Qsonica Sonicator  Qsonica Llc (Newtown, CT, USA)  
Sorvall RC 6+ centrifuge  ThermoScientific (Waltham, MA, USA)  
VivaspinTM Centrifugal 
Concentrators  
Vivaproducts Inc. (Littleton, MA, USA)  
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Table 2.1.3 Media 
 
Media  Composition  
Lysogeny-Broth 
(LB) + antibiotic 
1% (w/v) Casein peptone, 0.5% (w/v) yeast extract, 1% (w/v) 
NaCl + 100 μg/ml ampicillin *1.5% (w/v) bacteriological agar was 
added to make the equivalent agar plate 
Minimal Media  1.3% (w/v) KH2PO4, 1% (w/v) K2HPO4, 0.9% (w/v) Na2HPO4, 
0.24% K2SO4 (1.2% (w/v) glucose, 30 μg/mL thiamine, 10 mM 
MgCl2, 1% (w/v) trace metal solution, 0.0001% (w/v) yeast 
extract, and 100 μg/mL ampicillin), 
Media and agar plates were made using MQW and sterilised by autoclaving. Antibiotics 
were added following autoclaving.  
 
Table 2.1.4 Bacterial strains  
 
Bacterial strain  Genotype  
DH5α  supE44, ΔlacU169, [Φ80lacZΔM15], hsdR17, recA1, and A11, 
gyrA1, thi-I, relA1 (Bethesda Research Laboratories, 
Gaithersburg, Maryland, USA) 
BL21 (DE3)  F- ompT [Ion] hsdSB (rB- mB- : and E. coli B strain) (Integrated 
Sciences, Willoughby, NSW) 
The E. coli DH5α strain was used for cloning and plasmid production. Protein 
expression was induced in E. coli BL21(DE3).   
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Table 2.1.5 Buffers and solutions 
 
Buffers and 
Solutions 
Composition 
1x LDS loading buffer 
bromophenol blue 1x  
0.3125 M Tris pH 6.8, 10% (w/v) LDS, 50% (w/v) glycerol, 
0.5% (w/v) 
1x TAE buffer 40 mM Tris-acetate (pH 8.2), 1 mM EDTA 
1x MES running buffer  50 mM MES (pH 7.3), 50 mM Tris, 0.01% (w/v) SDS, 1 mM 
EDTA 
Coomassie gel stain 0.125% (w/v) Coomassie BBR, 40% (v/v) Methanol, 70%  
(w/v) Acetic acid  
De-stain  10% (w/v) Acetic acid, 30% (v/v) Methanol  
Ion exchange buffer 
A/ NMR buffer/ SEC 
buffer 
10 mM MES, pH 6.0, 50 mM NaCl 
Ion exchange buffer B  10 mM MES, pH 6.0, 1M NaCl 
KCM  500 mM KCl, 150 mM CaCl2, 250 mM MgCl2 
Lysis buffer 10 mM MES, pH 6.0, 500 mM NaCl, 0.5 mM PMSF, 1 
mg/mL DNAse and 1% Triton X-100 
Separation buffer  30 mM Tris, 0.5 mM EDTA, 500 mM NaCl, 20% glycerol 
SPR buffer 50 mM Tris, pH 7.6, 50 mM NaCl, 0.4 mM EDTA, 0.005% 
P20 (+ 0.5mM DTT for reduced)  
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Storage buffer  30 mM Tris, pH 7.6, 50 mM NaCl, 0.5mM EDTA, 30% 
glycerol.  
Trace Metal Solution 
(TMS) 
 216 mM FeSO4 * 7 H2O, 41 mM CaCl2 * 2 H2O, 6.35 mM 
MnCl2, 3.5 mM CoCl2, 2.4 mM ZnSO4 * 7 H2O, 1.9 mM 
CuSO4, 0.32 mM H3BO3, 0.2 mM (NH4) 6Mo7O24 * 4 H2O, 
17.1 mM EDTA 
Tris lysis buffer  20 mM Tris, pH 7.0, 500 mM NaCl, 0.5 mM PMSF, 1mg/mL 
DNAse and 1% Triton X-100 
Tris wash buffer  20 mM Tris, pH 7.6, 500 mM NaCl 
Tris ion exchange 
buffer A  
20 mM Tris, pH 7.6, 50 mM NaCl 
Tris ion Exchange 
buffer B  
20 mM Tris pH 7.6, 1 M NaCl 
Wash Buffer  10 mM MES, pH 6.0, 500 mM NaCl 
**Note: ‘Reduced’ occurring before buffer name indicates an addition of 3mM TCEP-
HCL to the solution/buffer detailed above. TCEP-HCL has previously been established 
to prevent oligomer formation in hSSB1 (39).  
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2.2 Cloning  
 
2.2.1 E. coli transformation  
 
Bacterial transformations were accomplished through the addition of 50 µL KCM and 
3 µL (of approx. 240 ng/µL) plasmid to 50 µL chemically competent E. coli cells. 
Transformation mixtures were incubated on ice for 15 min, heat shocked at 42ºC for 
90 s, incubated in LB for 1 h at 37ºC and plated on LB agar containing AMP. Plates 
were incubated for 15 h at 37ºC.  
 
2.2.2 Plasmid production  
 
The hSSB1(1-123) gene was restriction digested from a generic plasmid using the 
restriction endonucleases BamHI and EcoRI according to the manufacturer’s 
instructions and ligated in frame into the pGEX6P vector, using the same restriction 
sites, to create an N- terminal GST-fusion protein. Digested DNA and linearised 
plasmid were subjected to agarose gel electrophoresis and the desired bands were 
excised from the gel. hSSB1(1-123) genes and pGEX6P vector excised from agarose 
gels were purified using the QIA quick Gel Extraction Kit 250 (Qiagen). 
 
The pGEX6P vector and hSSB1(1-123) inserts were ligated (at a ratio of 1:3) with 
QuickStick DNA ligase (Bio-line). Ligated plasmids were transformed into chemically 
competent DH5α cells and plated on LB Agar containing AMP. Colonies of this ligation 
plate were used to inoculate 10mL of LB + AMP. Cultures were incubated for 15 h at 
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37ºC. The Isolate II Plasmid Minikit (Bio-line) was used to isolate plasmid DNA from 
transformed cells. Restriction enzyme cleaved plasmid was run on a DNA gel (see 
section 2.5.1) to confirm the success of the cloning process. 
 
2.3 Expression and purification of hSSB1(1-123)  
 
2.3.1 Unlabelled hSSB1  
 
The pGEX6P-h1OB1 plasmid was transformed into BL21(DE3) cells. A single colony 
was used to inoculate 10 mL LB + AMP. This culture was incubated for 15 h at 37ºC 
and subsequently used to inoculate 1L LB + AMP. The 1L culture was incubated at 
37ºC, shaking at 150 rpm until the OD reached A600 ~ 0.5. When the desired OD was 
reached, expression of the hSSB1(1-123)-GST fusion protein was induced by the 
addition of 0.2 mM IPTG for 15 h at 20°C. 
 
2.3.2 15N/13C labelled hSSB1  
 
Isotopically single labelled (15N) and double labelled (15N/13C) hSSB1(1-123) were 
prepared in a fermenter to allow for nitrogen and carbon levels to be monitored and 
the source of nitrogen and carbon to be changed to 15NH4Cl and 13C-glucose before 
expression was induced.  
 
A single colony of BL21(DE3) transformed with pGEXP-h1OB1 was used to inoculate 
5 mL LB + AMP. The 5 mL day culture was then incubated at 37ºC, shaking at 150 
 21 
 
rpm for 7 h and used to inoculate 1L of minimal media containing ~0.2% (W/V) 
unlabelled ammonium chloride (single labelled preps) or labelled ammonium chloride 
(double labelled preps). The 1L culture was incubated for 15 h at 37ºC, shaking at 150 
rpm and was used to inoculate 2L of minimal media in 5L fermenter.  
 
The 3L culture was grown at 37ºC and agitated at 1000 rpm, with oxygen levels being 
monitored (set to between 90-100% at time of inoculation of 2L minimal media). A spike 
in oxygen levels indicated that cells had depleted the nitrogen source. If at the time of 
this spike the OD of the culture was Abs600 4-6, ~ 3.75 g of labelled ammonium chloride 
was added to the culture and expression was induced by the addition of 0.2mM IPTG. 
Expression continued for 3h at 25ºC.  
 
2.3.3 Cell lysis  
 
Cells were centrifuged at 5000 rpm for 15 minutes at 4◦C and the cell pellets were 
harvested. Cells were then lysed by sonication (1 x 1min) in lysis buffer (20mL/5g). 
Lysed cells were centrifuged at 11000 rpm for 30 min at 4◦C to separate insoluble cell 
debris and the soluble cell lysate.  
 
2.3.4 Glutathione Sepharose (GSH) affinity chromatography  
 
The supernatant was run through Glutathione Sepharose (GSH) affinity 
chromatography. The protein was cleaved from GSH beads for 15 h at 4◦C using HRV-
3C protease, leaving a 5-residue (GPLGS) stretch at the N-terminus of the OB domain.  
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2.3.5 Heparin affinity chromatography 
 
The eluates from GSH affinity chromatography were subjected to heparin affinity 
chromatography in a HiTrap HP Heparin column (5 ml GE) equilibrated with ion 
exchange buffer A. The hSSB1 protein was eluted from the column by increasing salt 
concentration (50-1000 mM NaCl gradient). Fractions correlating to a distinct peak in 
UV absorbance (280 nM) were collected and concentrated in preparation for analysis.  
 
2.4 DNA preparation 
 
All DNA sequences (Appendix A) used for analysis were obtained HPLC purified 
directly from the supplier. Lyophilised DNA was prepared in the same buffer as the 
protein for NMR and SPR experiments. For dsDNA samples, the two strands were 
annealed by heating. To ensure that no ssDNA was present in dsDNA samples, 
annealed DNA was run through SEC.  
 
2.4.1 Size Exclusion Chromatography (SEC)  
 
A Superdex 75 chromatography column pre-equilibrated with SEC buffer was used to 
separate annealed DNA from ssDNA. The column was operated on an NGC 
chromatography system (Bio-Rad). Absorbance was monitored at 260 nm and 280nm. 
Fractions correlating to distinct peaks in absorbance were collected.  
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2.5 DNA and protein analysis 
 
2.5.1 DNA gels 
 
DNA samples were prepared by the addition of 1x GelPilot loading dye (Qiagen) and 
run through a 1% (w/v) TAE-agarose gel supplemented with 0.0001% (v/v) gel red. 
Samples were run at 110 V for 30 min and DNA bands were visualised using a UV light 
trans-illuminator. 
 
2.5.2 Protein gels (SDS-PAGE)   
 
Protein samples containing 1x LDS loading dye were loaded onto pre-cast NuPAGE 
Bis-Tris Mini gradient gels (4-20%). The Mark12 molecular weight standard was also 
run. Samples were run for 20 min at 180 V in MES running buffer. Gels were stained 
with Coomassie brilliant blue for 30 min and de-stained using de-stain solution for 2 h 
for visualisation.  
 
2.6 NMR spectroscopy  
 
Purified protein samples were prepared in NMR buffer with 10% D2O and 20 µM DSS.  
One dimensional (1D) and two dimensional (2D) spectra were acquired on a Bruker 
Avance 600 MHz or 800 MHz spectrometer at 25ºC using a standard 1D and 2D pulse 
program respectively. All spectra were processed using TOPSPIN (Bruker, Biospin) 
with reference to the chemical shift of DSS (0 ppm) and assignments were made using 
Sparky (T. D. Goddard and D.G. Kneller, University of California at San Francisco).  
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The calculation of weighted chemical shift changes was carried out as described in 
(44) using OriginPro 2017 (OriginLab Corporation, Northampton, MA, USA). All NMR 
figures were edited using Adobe Illustrator 2017.0.2 (Adobe Inc., San Jose, CA, USA. 
 
2.7 Surface Plasmon Resonance (SPR)  
 
All SPR experiments were achieved using a BIAcore 2000 (in collaboration with the 
University of Wollongong) and utilised affinity immobilization using the strong non-
covalent interaction of the biotin-streptavidin system. Biotinylated ssDNA with a 3A 
spacer was injected into flow cell 4 of a SA chip at a flow rate of 20 µL/min for 180 s. 
Approximately 70 RU of DNA was immobilized onto the surface of flow cell 4. Flow cell 
1 acted as a control. Solutions of purified hSSB1(1-123) (various dilutions in SPR 
buffer) were injected for 20 s at a flow rate of 20 µL/min order to determine a KD (Fig 
8). Flow cells were regenerated with 1 min injections of 1M MgCl2 at 5 mL/ min. Data 
obtained from SPR experiments was analysed using BIAevaluation 4.1.1. Regions 
chosen to determine equilibrium values were selected at the point of saturation (the 
region where stabilisation of the curve was seen; a region is necessary as the curve 
will never be completely stable).  All SPR figures presented in this thesis were created 
using OriginPro 2017 (OriginLab Corporation, Northampton, MA, USA) and edited 
using Adobe Illustrator 2017.0.2 (Adobe Inc., San Jose, CA, USA).  
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2.8 HADDOCK modelling  
 
The tetramer model presented by Touma et al 2017 (36) was modelled together with 
ssDNA (oligo12T) using the same restraints as in (40).  hSSB1 residues 15–17, 26–
40, 52–63 and 73–91 were defined as semi-flexible and all twelve thymines of the 
ssDNA were defined as semi-flexible and flexible. Eighty-three ambiguous interaction 
restraints for the protein and ssDNA were selected and fixed at 2 A˚. Additional 
restraints to maintain base planarity between the four aromatic residues (W55, Y74, 
F78 and Y85) and ssDNA bases THY2, THY3, THY5, THY8, THY10 and THY11 as 
well as the overall symmetry of the hSSB1 oligomer were used in the calculations. The 
10 conformers with the lowest value of total energy of the lowest-energy cluster were 
analysed and visualized using PYMOL (Schrödinger, NY).  
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3. Defining the molecular details of hSSB1 oligomer binding to 
oxidatively damaged dsDNA  
 
3.1 Introduction  
 
It has been well established that hSSB1 binds to and protects DNA when it exists in its 
single stranded form. The hSSB1 oligomer is also known to be necessary for the 
removal of 8-oxoG from the genome. However, the ability of hSSB1 to recognise and 
bind to oxidatively damaged bases when DNA strands form part of a duplex is not well 
understood. NMR spectroscopy techniques were applied in order to address this gap 
in knowledge.  
 
NMR spectroscopy is an essential tool in the study of protein structure and allows for 
an increased understanding of the dynamics and interactions of proteins in solution 
(45). There are a number of different types of spectra that can be obtained using NMR. 
The simplest NMR experiment results in a 1D 1H NMR spectra that displays signals 
obtained from the protons of molecules as sharp peaks, each representing a proton in 
a distinct chemical environment. The presence of these distinct peaks in the spectra of 
a protein indicates that the protein is folded. Performing 1D 1H NMR analysis of dsDNA 
also allows us to see distinct signals from the hydrogen bonding between DNA bases. 
When a change in the chemical environment of a base occurs, such as the binding of 
a hSSB1 protein, these peaks will shift their position in the resultant 1D 1H NMR 
spectrum.  
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Standard 2D and 3D NMR experiments have already been utilised to gain full 
assignments of reduced (monomeric) 15N13C-labelled hSSB1 (46). Signals from both 
1H and labelled 15N atoms are displayed in 2D spectra (H and N). Each signal 
represents a single amide bond (1 residue). Shifts in the signal indicate a change in 
chemical environment of the residue.   
 
This chapter describes the use of 1D 1H NMR (DNA signals) and 2D 1H-15N (HSQCs, 
protein) NMR spectroscopy to determine the structural details of oligomeric hSSB1 
recognition of oxidatively damaged dsDNA. 
 
3.2 hSSB1 unwinds dsDNA and binds to its single strands  
 
Signals from the hydrogen bonds formed between the base pairs of the 8-oxoG dsDNA 
sequence can be seen in the region of 14.5-12.0 ppm (imino region) of the 1D 1H NMR 
spectra obtained (Fig 7 A). To determine the region of 8-oxoG dsDNA to which hSSB1 
binds (e.g., the site of a mismatch/8-oxoG or the ends of dsDNA) the signals were 
assigned to their correlating bases (Fig 7 A) using 2D 1H-1H NMR (NOESY) 
experiments (Appendix B).  
 
The assigned 8-oxoG dsDNA peaks in the imino region were then analysed in the 
absence and presence of non-reduced (oligomeric) hSSB1(1-123). Apart from a peak 
broadening consistent with protein binding, shifts were seen in the peaks correlating to 
the DNA bases G4, T36 and G37 (Fig 7 A) which are all located on the left-hand side 
(LHS) of the 8-oxoG base in the dsDNA sequence. The position of the bases seen to 
 28 
 
shift suggest that a change in chemical environment occurs on the LHS of the 
sequence, indicating that hSSB1 binds to bases on the right-hand (RHS) of the dsDNA. 
 
As hSSB1 binds ssDNA, it is likely that the two dsDNA strands separate before binding 
occurs. To examine this, the same solution of hSSB1(1-123) bound to 8-oxoG dsDNA 
was subjected to 2D 1H-15N HSQC NMR experiments. The 1H-15N HSQC spectra 
obtained of hSSB1(1-123) bound to 8-oxoG dsDNA was compared to hSSB1(1-123) 
bound to single stranded oligo12T DNA (Fig 7 B). The spectra of the bound protein (to 
the dsDNA and ssDNA sequences) are very similar. This indicates that, in both cases, 
hSSB1 is bound to exposed ssDNA and this suggests that hSSB1(1-123) is able to 
penetrate the double helix, open up the dsDNA and bind to the newly exposed single 
strands on the right-hand side (RHS) of the 8-oxoG base in the dsDNA sequence. The 
presence of the bound protein on the ssDNA of the RHS of the sequence causes a 
shift in the peaks corresponding to base pairs of the LHS (which have hydrogen bonds 
that have remained intact). Given that imino signals were still observed on the right-
hand side (RHS) of the dsDNA (indicating the presence of intact hydrogen-bonds), a 
mixture of fully annealed dsDNA and hSSB1-bound ds/ssDNA is present in solution 
(see Fig 7 C). 
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Figure 7.  hSSB1(1-123) binding to 8-oxoG dsDNA. A) Assigned one dimensional (1D) 1H NMR 
spectra of 8-oxoG dsDNA in the absence (black) and presence (blue) of non-reduced hSSB1(1-
123). DNA bases seen to shift after the addition of non-reduced hSSB1(1-123) are highlighted 
(red text) in the DNA sequence. Red arrows indicate the position of the highlighted DNA bases 
in the 1D 1H NMR spectra.  B) Assigned two dimensional (2D) 1H-15N HSQC spectra of hSSB1(1-
123) bound to 8-oxoG dsDNA (red) and hSSB1(1-123) bound to oligo12T DNA (blue). C)  
Schematic of hSSB1-bound ds/ssDNA and fully annealed dsDNA present in solution. DNA is 
represented by black lines, hSSB1 is represented as blue circles.   
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The 1D 1H NMR data gathered using several other dsDNA sequences (with multiple 
G:C base pairs present at both ends of the sequence) displayed no change in the 
presence of hSSB1(1-123) (example spectra shown in Fig 8, all other sequences 
shown in Appendix C) indicating either no binding or very weak binding. In contrast, in 
the case of the 8-oxoG dsDNA, the NMR data suggest that hSSB1 may have unwound 
the helix, either from the ends that are made up of weaker A:T base pairs on the RHS 
of 8-oxoG dsDNA, or through the site of 8-oxoG damage (see discussion). 
 
 
Figure 8.  hSSB1(1-123) binding to dsDNA that contains terminal GCC nucleotides. One 
dimensional (1D) 1H NMR spectra of dsDNA containing terminal GCC nucleotides (red text) and 
a G:C mismatch (blue text) in the absence (black line) and presence (blue line) of non-reduced 
hSSB1(1-123).  
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4. Defining the molecular details of hSSB1 oligomer binding to 
oxidatively damaged ssDNA  
 
4.1 Introduction 
 
In chapter 3, I establish that hSSB1 binds to damaged dsDNA when it is unwound into 
its single strands. However, whether the presence of 8-oxoG causes a change in the 
binding mechanism of hSSB1 remains unclear.  
 
The hSSB1 oligomer displays an ability to bind to dsDNA containing a single 8-oxoG 
that the hSSB1 monomer lacks (39). This ability to bind dsDNA that contains a single 
8-oxoG and the role of the hSSB1 oligomer in the repair of oxidative damage suggests 
that the hSSB1 oligomer may have the ability to differentiate the 8-oxoG base from 
unmodified DNA bases and bind accordingly. Additionally, structural differences 
between the binding of oligomeric and monomeric hSSB1 to ssDNA are still 
undetermined.  
 
In order to fill these gaps in knowledge a structural analysis of hSSB1(1-123) binding 
to unmodified ssDNA and 8-oxoG containing ssDNA was undertaken using 2D 1H-15N 
HSQC NMR experiments. The binding of oligomeric, compared to monomeric hSSB1 
to ssDNA was also examined using 2D 1H-15N HSQC NMR techniques. As the hSSB1 
monomer binds to DNA with a 6-base binding footprint (38, 46), an oligo length of 6 
bases was used to compare the binding of hSSB1 to damaged versus undamaged 
ssDNA.  However, when determining differences between the binding mechanisms of 
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oligomeric and monomeric hSSB1, an additional oligo length of 12 bases was also 
examined to allow for the binding of hSSB1 oligomers. The addition of 3 mM TCEP-
HCL was used to ensure that only monomers were present for ‘monomeric hSSB1’. 
The use of 3 mM TCEP-HCL has previously been established to prevent oligomer 
formation in hSSB1 (39). 
 
4.2 hSSB1 binds to oligo6T ssDNA with the same mechanism regardless of redox 
status or the presence of damage   
 
2D 1H-15N HSQC NMR spectra were used to compare the binding of hSSB1 to ssDNA 
in the presence (5ToxoG) and absence (oligo6T) of 8-oxoG. The same residues are 
seen to shift in hSSB1(1-123) bound to oligo6T and 5ToxoG ssDNA (Fig 9 E, F). This 
result suggests that the binding mode of hSSB1 (intercalation with key aromatic 
residues, see ref (40)) remains the same whether or not 8-oxoG is present. Inspection 
of the chemical shift profiles reveals that the same set of residues also exhibit higher 
than average weighted chemical shift changes (Fig 9 B, C), further confirming that 
hSSB1 binds ssDNA with the same mechanism in the presence and absence of 8-
oxoG. As no difference in hSSB1 interaction with 8-oxoG compared to undamaged 
bases was seen, all subsequent experiments were performed on undamaged ssDNA 
sequences.  
 
To determine if there is a difference in ssDNA binding between monomeric and 
oligomeric hSSB1, further NMR experiments of the same type (2D 1H-15N HSQCs) 
were undertaken to compare the binding of non-reduced (oligomeric) and reduced 
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(monomeric) hSSB1 to oligo6T ssDNA. The same residues were seen to shift in non-
reduced hSSB1(1-123) and reduced hSSB1(1-123) when bound to oligo6T DNA (Fig 
9 A, B) and the chemical shift profiles show that the same residues displayed higher 
than average weighted chemical shift changes (Fig 9 D, E). This result suggests that 
the monomer and oligomer bind to short strands of DNA in the same way.  
 
4.3 Oligomeric hSSB1 binds to oligo12T ssDNA via the same set of residues as 
monomeric hSSB1   
 
To further analyse differences between monomeric and oligomeric hSSB1-ssDNA 
interaction, the structural details of hSSB1 binding to oligo12T DNA (which is long 
enough to allow for the binding of at least two hSSB1 monomers) was assessed with 
NMR. The 2D 1H-15N HSQCs of non-reduced hSSB1(1-123) and reduced hSSB1(1-
123) bound to oligo12T DNA display very similar chemical perturbations (Fig 10 C, D) 
and the same set of amino acids exhibit significant shift changes (Fig 10 A, B). This 
suggests that multiple individual hSSB1 monomers (reduced protein) can localise to 
ssDNA in a similar manner to tetramers that are cross-linked via disulphide bonds (non-
reduced protein) prior to binding. These data introduce the question – why do hSSB1 
oligomers form in response to oxidative DNA damage? This question is addressed in 
chapter 5 using SPR experiments.  
  
 
3
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Figure 9. hSSB1 binds to oligo6T with the same mechanism regardless of the presence of 8-oxoG and oligomeric state.  
Chemical shift profiles of hSSB1(1-123) A) under reduced conditions (presence of TCEP, monomeric) bound to oligo6T 
ssDNA, B) under non-reduced conditions (absence of TCEP, oligomeric) bound to oligo6T ssDNA and C) under non-reduced 
conditions (absence of TCEP, oligomeric) bound to 5ToxoG ssDNA. Residues that show a higher than average chemical shift 
are highlighted in red. Assigned 2D 1H-15N HSQC spectra of unbound (grey) and bound (red) hSSB1(1-123) D) under reduced 
conditions (presence of TCEP, monomeric) bound to oligo6T ssDNA, E) under non-reduced conditions (absence of TCEP, 
oligomeric) bound to oligo6T ssDNA and F) under non-reduced conditions (absence of TCEP, oligomeric) bound to 5ToxoG 
ssDNA.  
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Figure 10. hSSB1 binds to oligo12T with the same mechanism regardless of oligomeric state.  
Chemical shift profiles of hSSB1(1-123) A) under reduced conditions (presence of TCEP, 
monomeric) bound to oligo12T ssDNA, B) under non-reduced conditions (absence of TCEP, 
oligomeric) bound to oligo12T ssDNA. Residues that display a higher than average chemical 
shift are highlighted in red. Assigned 2D 1H-15N HSQC spectra of unbound (grey) and bound (red) 
hSSB1(1-123) C) under reduced conditions (presence of TCEP, monomeric) bound to oligo12T 
ssDNA, D) under non-reduced conditions (absence of TCEP, oligomeric) bound to oligo12T 
ssDNA. 
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5. Determining differences in the DNA binding affinity of 
hSSB1 monomer and oligomer  
 
5.1 Introduction 
 
It has previously been determined that non-reduced hSSB1 is required for the protein 
to function in the BER pathway (22). As the data presented in Chapter 4 demonstrate, 
the binding of monomeric and oligomeric hSSB1 is structurally similar. Although the 
same set of residues are involved in binding, the difference in binding affinity between 
these two species of hSSB1 has not been addressed. As small differences in the 
dissociation constant are difficult to determine, the method of choice is Surface 
Plasmon Resonance (SPR) (Fig 11). 
 
To determine the affinity of monomeric hSSB1 compared to oligomeric hSSB1 for 
3Aoligo6T and 3Aoligo12T ssDNA, a 3A spacer was added to the oligos used in other 
chapters of this thesis in order to increase the accessibility of the ssDNA to the protein. 
A 3A extension was chosen as hSSB1 preferentially binds to the smaller thymine bases 
(see introduction). SPR experiments were carried out using a BIAcore SPR system. 
SPR is a highly sensitive, label free detection method that can be used to monitor the 
interaction between two molecules, one of which must be immobilised on a chip (47).  
This allows for interaction to be recorded when the binding partner is introduced, and 
also provides information on the kinetics of the reaction  (48, 49). 
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Binding curves were produced by plotting the difference between the baseline and 
equilibrium of varying hSSB1(1-123) concentrations (see methods). The dissociation 
constant (KD) and Rmax of each interaction was derived from the correlation between 
the equilibrium values of the binding curve, and the hSSB1(1-123) concentration by 
fitting data to the Hill Equation (50).  
 
 
 
𝑦 = 𝑅𝑚𝑎𝑥
𝑥𝑛
𝐾𝐷
𝑛 + 𝑥𝑛
  
 
 
Where,  
𝑦 = relative change in θ (RU)  
R𝑚𝑎𝑥 = point at which the ligand is saturated by analyte.  
n = cooperativity (fixed to one for all calculations as a 1:1 binding has been established 
with a DNA binding footprint of 5-6 thymines)  
𝑥 = protein concentration (µM) 
𝐾𝐷 = Dissociation constant (the lower the 𝐾𝐷, the higher the binding affinity) 
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Figure 11. SPR experimental procedure. DNA (cyan) is immobilised on the surface of a chip 
functionalised with streptavidin (horizontal black rectangle), using a biotin tag (orange).  Protein 
(green circles) is then injected into the flow cell. Interaction of protein and DNA results in a 
change in the angle (ϴ) of light detected.  
 
5.2 Oligomeric hSSB1 has a higher affinity for ssDNA than monomeric hSSB1  
 
SPR analysis using a BIAcore system was carried out to test binding of the hSSB1 
monomer (reduced) and oligomer (non-reduced) to 3Aoligo12T and 3Aoligo6T ssDNA 
(a 3A extension linker was used to make immobilised DNA more accessible to the 
protein) and provide quantitative affinity measurements of this interaction. All SPR 
experiments were carried out in collaboration with the University of Wollongong 
(UOW). All SPR experiments were carried out with a range of protein concentrations. 
An average of the response was taken at the point of equilibrium for each concentration 
(Fig 12). The average equilibrium values were plotted against concentration and 
plotted data fitted to the Hill Equation (Fig 13).  
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Oligomeric hSSB1 demonstrated a higher affinity for 3Aoligo12T ssDNA. A KD of 0.58 
± 0.05 µM was calculated for oligomeric hSSB1(1-123) binding to 3Aoligo12T DNA, 
while a KD of 1.31 ± 0.10 µM was determined for monomeric hSSB1(1-123) when 
tested with 3Aoligo12T DNA (Fig 14). A higher affinity for oligomeric compared to 
monomeric hSSB1(1-123) binding to oligo6T DNA was also seen.  A KD of 1.14 ± 0.04 
µM for hSSB1-3Aoligo6T binding was determined under non-reducing conditions, 
while a KD of 4.37 ± 0.27 µM was calculated for experiments undertaken under reduced 
conditions (Fig 13). All SPR experiments require repetition in order to determine if the 
differences in binding affinity seen here are significant.   
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Figure 12. Oligomeric hSSB1 has a higher affinity for ssDNA than monomeric hSSB1.  Fitted SPR 
data for A) Oligomeric hSSB1(1-123) and 3Aoligo12T. Values between 371-392 s (red) were used 
to determine average equilibrium value (red), B) monomeric hSSB1(1-123) and 3Aoligo12T. 
Values between 5.7 s and 17.2 s (red) were averaged to calculate the equilibrium value for each 
concentration C) oligomeric hSSB1(1-123) and 3Aoligo6T. Values between 378 S and 392 s (red) 
were averaged to calculate the equilibrium value of each concentration. D) monomeric hSSB1(1-
123) and 3Aoligo6T. Values between 3.3 s and 18.6 s (red) were averaged to determine the 
equilibrium value of each concentration.   
 41 
  
The Rmax was also calculated using the Hill Equation. The Rmax is proportional to the 
amount of protein bound (higher Rmax, more protein bound).  An Rmax of 437.18 ± 
14.48 for non-reduced binding to 3Aoligo12T, 313.69 ± 7.92 for reduced binding to 
3Aoligo12T, 367.42 ± 5.06 for non-reduced binding to 3Aoligo6T and 306.08 ± 7.56 for 
reduced binding to 3Aoligo6T was determined. While non-reduced hSSB1 bound to 
3Aoligo12T displayed the highest Rmax (indicating that more molecules of protein are 
bound to DNA) and small errors were calculated on the fit, the differences are not large, 
and replicates of the SPR experiments presented here are necessary to determine if 
any differences seen are significant.  
 
The data presented in this chapter reveal a higher affinity for oligomeric (non-reduced) 
hSSB1(1-123) binding to ssDNA. Additionally, by comparing hSSB1 binding to 
3Aoligo6T and 3Aoligo12T, these data reveal a difference in affinity for different oligo 
lengths of DNA, regardless of the oligomeric state of the protein. These findings 
suggest that, although under reduced conditions multiple hSSB1 monomers can bind 
to DNA, the presence of pre-formed oligomers in solution under non-reduced 
conditions results in tighter binding. 
 
As previously established by Touma et al 2017 (36) when hSSB1 is under non-reduced 
conditions, while oligomers can form, over 70% of the solution being analysed is still 
monomeric. This means that the equilibrium point of multiple different species is being 
seen in the SPR results presented here and provides some indication as to why the 
difference in the affinity between monomer and oligomer are relatively small (Fig 14). 
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The increase in association times necessary to reach equilibrium and the slower off 
rates seen for the oligomer (Fig 12 A, C) compared to the monomer (Fig 12 B, D), do 
however suggest that even if the differences in KD are not large, there is a difference 
in how the oligomer binds, compared to the monomer. This may also, however, be the 
result of precipitation on the DNA or the SPR chip and additional analysis is necessary 
before further conclusions can be made.  
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Figure 13. Averaged equilibrium values plotted against hSSB1 concentration (µM) and binding 
curves fitted to the Hill equation for A) oligomeric hSSB1 binding to 3Aoligo12T and B) 
monomeric hSSB1 binding to 3Aoligo12T C) oligomeric hSSB1 binding to 3Aoligo6T and D) 
monomeric hSSB1 binding to 3Aoligo6T.  
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Figure 14. Column graph displaying dissociation constants (KD) ± error calculated using the Hill 
Equation for reduced (monomeric) hSSB1 (1-123) binding to 3Aoligo12T, non-reduced 
(oligomeric) hSSB1(1-123) binding to 3Aoligo12T, reduced (monomeric) hSSB1 (1-123) binding 
to 3Aoligo6T, non-reduced (monomeric) hSSB1 (1-123) binding to 3Aoligo6T. 
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6. Determining structural differences in hSSB1 binding to 
ssDNA strands of increasing length 
 
6.1 Introduction  
 
As previously described, only a single hSSB1 monomer can bind to a strand of DNA 
that is 6 bases long. An oligo length of twelve bases may allow for the binding of two 
or more hSSB1 molecules. Hence analysis of the binding of hSSB1 to these different 
oligo lengths (6 nucleotides compared to 12 nucleotides) may elucidate details of 
structural differences between oligomeric (multiple molecules of hSSB1) and 
monomeric (a single hSSB1 molecule) binding to ssDNA.  
 
As described in chapter 4, when the binding of reduced and non-reduced hSSB1 to 
ssDNA is compared, the same residues are seen to be involved in binding to DNA 
regardless of the oligomeric state of hSSB1. Additionally, Chapter 5 reveals that 
oligomeric hSSB1 has a higher affinity than monomeric hSSB1 for oligo6T and 
oligo12T. Differences in the affinity of hSSB1 for different oligo lengths were also seen. 
The structural mechanism underlying these differences in affinity are not clear. In this 
chapter I examine structural differences in hSSB1 binding to DNA strands of varying 
length through the application of 2D 1H-15N HSQC NMR spectroscopy techniques in 
order to determine differences in the binding mechanism of monomeric and oligomeric 
hSSB1.  
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6.2 Residues R88 and G89 show higher than average chemical shifts when oligomer 
binds ssDNA 
 
Structural analysis by 2D 1H-15N HSQC NMR revealed that the same residues are seen 
to shift in oligomeric hSSB1 bound to oligo6T when compared to oligo12T (Fig 15 A, 
B, D, E). However, significantly larger shifts are seen in residues R88 and G89 when 
the oligomeric protein is bound to longer strands of ssDNA (Fig 15 C, F). These 
residues are located at the protein-protein interface in the hSSB1 tetramer (Fig 18 C) 
as well as the DNA binding interface of the protein.  This suggests that hSSB1 
tetramers (held together by disulphide bonds in the non-reduced environment) might 
be able to directly bind longer strands of DNA.  
 
To further confirm this, 2D 1H-15N HSQC NMR experiments were undertaken using the 
non-reduced hSSB1-ssDNA complex. TCEP-HCL was added in an attempt to reduce 
hSSB1 to its monomeric state. TCEP-HCL was added in two steps, first at a 
concentration of 100 mM, then at a final concentration of 200 mM.  
 
The first addition of TCEP-HCL resulted in a slight shift of the G89 and R88 residues 
back towards its unbound state, indicating that the ratio of free DNA to protein had 
increased, and that the protein had begun to dissociate from the DNA. The second 
addition of TCEP-HCL resulted in a significant reduction of hSSB1(1-123) bound to the 
oligo12T as seen from the movement of both R88 and G89 moieties back towards their 
unbound state (Fig 16).  
  
  
4
7
 
Figure 15. hSSB1 residues R88 and G89 show increased shifts when hSSB1 binds 12 nucleotides of ssDNA. Chemical shift 
profiles of non-reduced hSSB1(1-123) bound to A) oligo6T ssDNA, B) oligo12T ssDNA. C) difference in chemical shifts 
between oligo12T and oligo6T. Residues that show a larger than average chemical shift change are highlighted in red.  
Assigned 2D 1H-15N HSQC NMR spectra of non-reduced hSSB1(1-123) bound to D) oligo6T ssDNA, E) oligo12T ssDNA. F) 
difference in G89 chemical shifts between oligo12T and oligo6T. 
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The location of both R88 and G89 peaks after the addition of TCEP are consistent with 
hSSB1 monomer binding to shorter ssDNA oligos such as the oligo6T (Fig 9 A, D) 
indicating that the addition of TCEP-HCL leads to a major reduction in the ability of the 
protein to remain bound to the oligo12T. However, a complete shift back to the 
unbound state is not seen.  
 
One possible explanation for this effect is that TCEP-HCL leads to a major disruption 
of the intermolecular binding interface between the previously disulphide-bonded 
hSSB1 monomers.  The hSSB1 may initially be removed from the DNA but 
subsequently be able to bind back onto the DNA. The spectra obtained displays an 
‘average’ of all the different states of the protein (in this case bound and unbound). 
Another possibility is the effect of ion strength in decreasing hSSB1-DNA interaction.  
As protein-DNA interaction is largely electrostatic in nature, the high concentrations of 
TCEP-HCL, a hydrochloride salt, could result in the reduction of hSSB1 bound to DNA 
seen in the spectra (Fig 16).  
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Figure 16. The addition of TCEP-HCL to non-reduced hSSB1 bound to oligo12T ssDNA results 
in the return of hSSB1 to its unbound state. 2D 1H-15N HSQC NMR spectra of the G89 residue of 
non-reduced hSSB1(1-123) unbound (grey) and bound (red) to oligo12T ssDNA. The shift of 
residue G89 after the addition of 100 mM TCEP-HCL is shown in yellow, the shift after the second 
addition of 100 mM TCEP-HCL is displayed in orange.  
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7. Proposing a hSSB1 tetramer – ssDNA binding model  
 
7.1 Introduction  
 
The mechanism by which the hSSB1 monomer binds to DNA has been established 
(Fig 17) (40). The interaction surface between the four hSSB1 monomers which come 
together to form disulphide-bonded homo-tetramers (under non-reduced conditions) 
has also been determined (see also Fig 6) (36). 
 
 
 
 
 
Figure 17. Cartoon (hSSB1) and stick (ssDNA) representation of the solution model of 
monomeric hSSB1-ssDNA complex (Figshare data repository DOI: 
10.6084/m9.figshare.4892129).  The four aromatic residues involved in base stacking (W55, Y74, 
F78, Y85) are indicated.  
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Data presented in this thesis has found that there is slight increase in the binding 
affinity of hSSB1 for longer strands of ssDNA under conditions that allow for hSSB1 
oligomerisation, despite the fact that the same set of residues are interacting with the 
DNA. However, hSSB1 residues that exhibit larger changes when bound to longer 
strands of DNA (R88 and G89) compared to shorter strands of DNA have been 
identified. In addition, I have shown that the reduction of the disulphide bonds of DNA-
bound oligomeric hSSB1 results in a decrease in the ability of the protein to remain 
bound to DNA. Overall, these data strongly indicate that hSSB1 binds to ssDNA not 
only as a monomer, but under non-reduced conditions binds as a tetramer that is 
structurally homologous to the one previously described in solution. 
 
In this chapter I present a model of a disulphide-bonded hSSB1 tetramer bound to 
oligo12T ssDNA based on the data collected from our structural and biophysical 
studies, the current tetramer model of self-oligomerisation and the hSSB1 monomer-
ssDNA binding model. 
 
7.2 DNA-binding model for tetrameric hSSB1 
 
The model presented here displays a disulphide-bonded hSSB1 tetramer bound to 
strands of oligo12T DNA (Fig 18 A). The same hSSB1 tetramer model presented by 
Touma et al. 2017 (36) was used, with the addition of two strands of oligo12T DNA 
modelled in (see methods). The two hSSB1 monomers that interact with the ssDNA 
(mon II and mon IV) are the only two monomers that are not disulphide-bonded (Fig 
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18 A, B), indicating that tetramer formation is necessary to bring these two monomers 
together in an orientation where binding can occur.  
 
The model of hSSB1 tetramer-DNA binding presented also takes into account that 
residues R88 and G89 come into close contact with the DNA as indicated by the NMR 
experiments of the previous chapter (Fig 18 C, D).  
 
In the model presented, I speculate that these hSSB1 molecules can bind in a defined 
orientation (as functional tetramers) when disulfide bonds are formed under oxidative 
conditions. Further research is necessary to validate the model of tetrameric hSSB1–
DNA binding presented here and to determine the different binding modes of hSSB1 
when disulfide bonds are not formed between hSSB1 subunits (see discussion and  
outlook). 
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Figure 18. Model of hSSB1 tetramer bound to oligo12T ssDNA. A) hSSB1 tetramer (cartoon) 
linked by disulfide bonds (yellow) bound to oligo12T ssDNA (stick). B) Two monomers that do 
not form disulfide bonds with each other (II and IV) indicate that tetramer formation brings these 
monomers together in an orientation where binding can occur. Position of R88 (red stick) and 
G89 (grey stick) residues displayed on C) Front and D) side view of the disulfide bonded (yellow) 
hSSB1 tetramer.     
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8. Discussion  
 
The most common form of damage encountered by DNA is oxidative damage caused 
by ROS (3). This oxidative damage includes the modification of the native guanine 
base to mutagenic 8-oxoG, which is removed through the action of the proteins of the 
BER pathway. Among the BER proteins is the single stranded DNA binding protein, 
hSSB1 (4).   
 
The hSSB1 protein exists in solution in multiple oligomeric states which is essential for 
its function in the different DNA repair pathways, including BER (22, 33-35, 39, 51, 52). 
The hSSB1 monomer binds ssDNA through a base-stacking mechanism of four key 
aromatic residues (W55, Y74, F78, F85). As previously described, the hSSB1 
monomer recognises DNA through its single OB fold as part of two complexes - the 
SOSS1 complex, where hSSB1 interacts with INTS3 via its OB fold and the MRN 
complex, which contacts hSSB1 via the flexible carboxyl tail. These interactions do not 
interfere with the ability of hSSB1 to form oligomers, which are necessary for the 
removal of 8-oxoG through BER (39).  
 
Here I discuss the molecular details of hSSB1 oligomerisation in response to oxidative 
DNA damage and the mechanism by which the hSSB1 oligomer binds DNA. 
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8.1 hSSB1 unwinds dsDNA and bind to its single strands 
 
The ability of hSSB1 to bind to ssDNA is crucial in its role in protecting damaged DNA 
and is imperative to its function in the BER pathway. While the danger in the 
accumulation of 8-oxoG in the genome lies with its ability to form hydrogen bonds with 
adenine bases and subsequently cause a mutagenic transversion to occur during 
replication, 8-oxoG mispairs with adenine at a similar rate that it base-pairs with 
cytosine (53). Watson-Crick base-pairing between cytosine and 8-oxoG causes a slight 
distortion in the dsDNA, meaning that in some cases of oxidative damage, there may 
be no ssDNA available for hSSB1 to bind to. This raises questions as to the mechanism 
by which hSSB1, a protein that binds ssDNA, is able to recognise and bind to sites of 
dsDNA damage.  
 
2D 1H-15N HSQC NMR and 2D 1H-1H NMR NOESY NMR experiments undertaken in 
chapter 3 examine the binding of oligomeric (non-reduced) hSSB1 to 8-oxoG dsDNA. 
The protein appeared to only bind to one half of the duplex (RHS), causing a shift in 
signals correlating to the base pairs located on the LHS of the duplex. While it is clear 
that protein-DNA interaction is occurring, whether hSSB1 was able to unwind the 
dsDNA duplex due to the presence of a slight 8-oxoG-induced distortion located in the 
middle of the sequence or initiate unwinding from the A:T rich (RH) end of the 
sequence is unclear. The sequence composition of the dsDNA provides insight into 
the likelihood of each possibility (hSSB1 entry from the ends of the sequence or entry 
from the site of damage).  
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The binding of complimentary base pairs (purine-pyrimidine) through hydrogen bonds 
is an important feature of DNA. Cytosine and guanine form three hydrogen bonds (as 
does 8-oxoG and cytosine), while thymine and adenine form only two. It follows that 
A:T base pairs are more easily separated (54). The sequence of 8-oxoG dsDNA 
(Appendix A, Table 2) contains thymine-adenine base pairs at the RHS and guanine-
cytosine base pairs at the LHS. As it is theoretically easier to separate the thymine-
adenine base pairs, it is plausible that in the experiments shown here, hSSB1 unwinds 
the duplex from the less strongly bonded end of the dsDNA sequence.  
  
In vivo, however, the organisation of DNA into chromatin and the length of DNA strands 
make it unlikely that hSSB1 will encounter the ends of a DNA strands (55). It can be 
hypothesised that for this reason, it is more likely for hSSB1 to localise to and bind 
DNA at sites of damage in cells.  Thus, I speculate that hSSB1 would be able to insert 
itself at sites of breaks or oxidative DNA damage, though further structural analysis is 
necessary to determine if this is the case. 
 
Regardless of where the protein inserts itself into the dsDNA, it is clear that, as would 
be expected, hSSB1 does not bind to dsDNA but rather binds to the ssDNA that 
becomes available once the duplex has been disturbed. The similarity between the 1H-
15N HSQC NMR spectra of hSSB1(1-123) bound to 8-oxoG ssDNA and hSSB1(1-123) 
bound to single stranded oligo12T DNA (Fig 7 B) confirms that hSSB1(1-123) is binding 
to the newly exposed single strands (Fig 7 C). For this to occur, hSSB1 oligomers must 
possess the ability to open-up damaged dsDNA and bind to its single strands. This 
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ability to destabilise duplex DNA has previously been described for SSBs including 
SsoSSB, RPA and EcoSSB (56-58).  
 
Further analysis is required to determine the role of different hSSB1 species in the 
binding of hSSB1 to sites of dsDNA damage and the separation of dsDNA strands. As 
mentioned previously, non-reduced hSSB1 contains a mixture of monomer, dimer, 
tetramer and higher oligomer, raising questions about the exact state that hSSB1 is in 
when recognising DNA (see discussion later in this chapter).  
 
8.2 hSSB1 recognises 8-oxoG base with the same mechanism as unmodified bases  
 
The bases present in a sequence of DNA impact the ability of hSSB1 to bind DNA (31, 
59). For example, possibly due to steric hindrance/ inefficient base stacking, the larger 
adenine base is less thermodynamically favourable for binding (60, 61). This is 
consistent with other SSBs, including SsoSSB, which like hSSB1 show the highest 
affinity for poly-thymines and lowest affinity for poly-adenines. The model of 
monomeric hSSB1-ssDNA binding displays base stacking of four aromatic residues 
(40). EcoSSB base stacks with two aromatic residues (41) and SsoSSB binds with 
three (43). Therefore, the dependency of binding on the DNA-base identity may be 
highest in hSSB1, though the opposite may also be true.   
 
In chapter 4, 2D 1H-15N HSQC NMR spectroscopy techniques were applied to 
determine how oligomeric hSSB1 binds ssDNA and ssDNA incorporating 8-oxoG 
bases. Our findings reveal that binding of non-reduced hSSB1 to 8-oxoG ssDNA is 
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indistinguishable to its binding to unmodified ssDNA, indicating no change in the 
underlying base-stacking mechanism, despite the previously published ability of 
oxidised hSSB1 to bind to 8-oxoG containing dsDNA and the role of hSSB1 in BER. 
This may be due to the structural similarity of 8-oxoG and native bases.  
 
The most common form of 8-oxoG (under physiological conditions) is 7,8-dihydro-8-
oxoguanine, which contains a carbonyl group at C8 and a protonated N7 (8-10).The 
resulting change in proton donors and acceptor enables the adduct to mimic  thymine 
when in the syn conformation, allowing for Hoogsteen base-pairing with adenine (10, 
62). Despite these changes, 8-oxoG remains structurally similar to the native guanine 
base. Therefore, it is highly likely that hSSB1 base stacks with the base as if it was an 
unmodified base. Unlike hSSB1, the bi-functional enzyme hOGG1 (a protein of the 
BER pathway that only localises to sites of oxidative damage if hSSB1 is present (22) 
has the ability to recognise 8-oxoG, and to distinguish between 8oxoG and the 
structurally similar, native guanine base (63, 64).  
 
8.3 hSSB1 recognises oligo12T DNA with an interaction interface that is independent 
of the oligomeric state 
 
The binding of oligomeric and monomeric hSSB1 to oligo6T was assessed in chapter 
4. The results indicate no difference in binding mechanism between monomer and 
oligomer. This is possibly due to the fact that only one monomer of hSSB1 is able to 
bind per strand of oligo6T DNA, regardless of its oligomeric state. A strand of DNA 
twelve bases long, however, has the ability to accommodate at least two molecules of 
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hSSB1.Therefore, 2D 1H-15N HSQC NMR spectroscopy techniques were subsequently 
applied to determine how oligomeric and monomeric hSSB1 binds undamaged ssDNA 
that is long enough to allow for multiple subunits to bind.  
 
Our findings reveal that the oligo12T-binding interface of reduced (monomeric) hSSB1 
is indistinguishable from that of non-reduced (oligomeric) hSSB1, further indicating that 
there is no change in the underlying base-stacking mechanism of DNA interaction 
between oligomeric and monomeric hSSB1.  
 
The similarity in the DNA-binding surface between the hSSB1 monomer and oligomer 
suggests that there is another underlying reason for the formation of oligomers under 
oxidative conditions. Subsequent SPR experiments were carried out to determine if 
there is a difference in the affinity of the different species of hSSB1 for ssDNA.  
 
8.4 Oligomeric hSSB1 binds to ssDNA with a higher affinity than monomeric hSSB1 
 
SPR experiments investigating monomeric and oligomeric hSSB1 binding to oligo12T 
ssDNA established that non-reduced (oligomeric) hSSB1 has a higher affinity (roughly 
2-fold) than reduced (monomeric) hSSB1. These data indicate that although multiple 
hSSB1 monomers can bind to ssDNA under reduced conditions, the presence of pre-
formed oligomers in solution under non-reduced conditions allows for tighter binding. 
 
While hSSB1 appears to have varying affinities for DNA depending on oligomeric state, 
other SSBs including EcoSSB and RPA, have been shown to display different binding 
 60 
  
modalities correlating to conformational changes that are vital for their function in 
ssDNA processing (65-67).  
 
RPA, another important human SSB, has varying affinities depending on the different 
configurations of its components. While hSSB1 contains a single OB domain and forms 
homo-tetramers, each subunit of which contains a single OB fold, RPA is a trimeric 
protein that possesses four different DNA binding OB domains across two (RPA 70 
and RPA 32) of the three different subunits (RPA 70, RPA 32 and RPA 14). RPA binds 
ssDNA in three known configurations. The first involves the second and third OB 
domains RPA 70 binding with a low affinity in a linear arrangement (binding 8 
nucleotides) (68).  The second configuration involves the three OB domains of RPA 70 
binding to 12-23 nucleotides (69, 70) and the third configuration also involves the one 
OB domain of RPA 32, which allows for binding with a higher affinity (to approx. 30 
nucleotides) (71, 72).  
 
8.5 Residues R88 and G89 are important for binding to longer DNA sequences 
 
The SPR experiments undertaken in chapter 5 also suggested that hSSB1 may bind 
to longer strands of DNA differently to short strands. When comparing the binding of 
oligomeric and monomeric hSSB1 to ssDNA, the same residues involved in DNA 
interaction are affected. Interestingly, when comparing binding of oligomeric hSSB1 to 
oligo6T (to which only one monomer can bind as hSSB1 has a 6-base binding footprint) 
and oligo12T (to which an oligomer could bind), significant changes in the chemical 
shifts of two residues (R88 and G89) located close to both the monomer-monomer 
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interface and the DNA binding OB folds of each monomer are seen when the protein 
binds to longer strands of DNA.  The shifts in these residues signify an interaction 
surface between the disulphide-bonded oligomer and DNA that does not occur in the 
presence of shorter strands of DNA.   
 
These findings demonstrate that longer strands of DNA are necessary to see an 
increased shift in R88 and G89, which aligns well to the model presented in chapter 7, 
where hSSB1 tetramers bind to DNA in the same formation previously described in 
solution. There is the possibility, however, that the increased shift is a result of longer 
strands of DNA wrapping around a single hSSB1 monomer or multiple hSSB1 
monomers binding independently of each other in a different orientation (Fig 19 C, D). 
This indicates that regardless of oligomeric state, residues R88 and G89 are impacted 
by the presence of longer strands of DNA.  
 
Under reduced conditions there are multiple orientations in which monomers can 
recognise DNA independently of each other (e.g, symmetrically, sitting directly on top 
of each other in the same orientation). There may even be a possibility of reduced 
hSSB1 forming a non-disulfide bonded tetramer (Fig 19 E). This is plausible as there 
are a number of residues, in addition to the ones that are disulfide bond linked (C81 
and C99), that are involved in hydrophobic and electrostatic interaction between 
monomers.  
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Figure 19. Representations of possible hSSB1 binding modes to 12 nucleotides of ssDNA. A) A 
model of a hSSB1 tetramer bound to a single strand of DNA B) A hSSB1 tetramer linked by 
disulfide bonds (yellow) bound to two strands of ssDNA C) hSSB1 monomers binding to ssDNA 
in the same orientation D) hSSB1 monomers binding to ssDNA symmetrically E) non-disulfide 
bonded tetramer binding to ssDNA.  
 
Further analysis was undertaken where non-reduced hSSB1 bound to oligo12T was 
reduced by the addition of TCEP. Both R88 and G89 residues were seen to begin to 
shift back to their unbound state in the presence of TCEP. This indicates reduction of 
the disulphide bonds and consequently disassembly of hSSB1 oligomers. Both R88 
and G89 form part of the interaction interface of two hSSB1 monomers in the tetramer 
model, indicating the possibility that hSSB1 has the ability to bind DNA bi-directionally 
(as shown in the model in Fig 19 B and Fig 20 B).  
 
EcoSSB also binds DNA as a homo-tetramer (26, 27, 41) and can do so in a number 
of binding modes, (EcoSSB)65 and (EcoSSB)35, which the protein transitions between 
depending on solution conditions, specifically salt concentration. When adopting the 
 63 
  
(EcoSSB)35 binding mode (low salt, high protein to DNA ratio) the tetramer binds 35 
nucleotides using only two of its four subunits. However, in the model of the (EcoSSB)65 
binding mode (high salt),  long strands ssDNA wind through the centre of the tetramer 
and orients as to bind each of the four subunits with the same directionality (Fig 20 A), 
as determined by crystallography (41) and Förster Resonance Energy Transfer (FRET) 
experiments (73).  In hSSB1, on the other hand, long strands of ssDNA may bind to 
hSSB1 straight up and down (Fig 20 B), indicating a change in the directionality of 
hSSB1 binding to DNA. However, further biophysical studies are required to confirm 
this hSSB1 tetramer-ssDNA complex model and the change in the binding polarity.   
Further, if hSSB1 penetrates dsDNA (as in chapter 3) as a tetramer, it is possible that 
this tetramer could bind the two separated strands simultaneously. This is again due 
to the orientation of the DNA binding groove of each of the four hSSB1 monomers, 
which remain aligned in a defined position due to the presence of disulfide bonds under 
non-reduced conditions. The DNA binding grooves of the EcoSSB tetramer, 
conversely, do not line up, forcing strands of ssDNA to wrap around the four monomers 
(Fig 20 A). The ability of hSSB1 to bind to the two separated strands of dsDNA (such 
as when a bubble is formed as a result of damage) would have implications in the 
ability of hSSB1 to protect the genome.  
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Figure 20. Comparing binding modes of hSSB1 and EcoSSB. A) EcoSSB tetramer bound to 
ssDNA (PDB ID 1EYG see ref (41)) B) data-based model of hSSB1 tetramer binding to two strands 
of ssDNA.  
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9. Conclusion  
 
The experiments presented in this thesis aimed to elucidate the molecular details of 
hSSB1 oligomerisation in response to oxidative DNA damage, though there is much 
that remains unknown.  This thesis describes the ability of hSSB1 to unwind dsDNA 
and determines that there is no difference in the binding mechanism when hSSB1 
binds to 8-oxoG containing DNA compared to unmodified DNA. Similarly, there is 
indistinguishable structural variation between the binding of oligomeric and monomeric 
hSSB1 to ssDNA. The findings presented in this thesis also reveal that oligomeric 
hSSB1 exhibits a higher affinity than monomeric hSSB1 for ssDNA and demonstrates 
that there is a structural difference in the binding of hSSB1 between short (6 
nucleotides) and long (12 nucleotides) strands of DNA in that the residues R88 and 
G89 experience higher than average chemical shifts more when the protein is bound 
to longer lengths of DNA compared to shorter DNA strands.  
 
The data collected and presented in this thesis suggest that multiple hSSB1 monomers 
can bind to a sequence of ssDNA, if it is long enough to accommodate them. While 
these data reveal many possibilities for multiple monomers binding to long strands of 
DNA, this thesis presents a model of how the previously determined disulfide bonded 
hSSB1 tetramer binds to ssDNA. Further research, however, is necessary to validate 
the model of tetrameric hSSB1–DNA binding presented here and to determine the 
different binding modes of hSSB1 when disulfide bonds are not formed between 
hSSB1 subunits.  
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10. Outlook 
 
10.1 Validation of tetramer binding model 
 
The model presented here is of a tetramer binding to oligo12T DNA, but I can also 
speculate about the possibility of other binding modes. Analysis of these possibilities 
is necessary in future. The directionality of hSSB1 DNA binding can be further analysed 
with 2D Paramagnetic Relaxation Enhancement (PRE) NMR techniques using 
paramagnetic-labelled oligos to determine the orientation of the protein when bound to 
DNA as previously achieved with SsoSSB (43). The binding polarity with which hSSB1 
binds DNA could also be investigated through the application of single molecule FRET 
experiments as previously described for EcoSSB (73).   
 
To further validate the model, SPR experiments like the ones presented here could be 
repeated on hSSB1 mutants. The N16D/N18D hSSB1(1-123) domain mutant has 
previously been established to disrupt tetramer formation (36).  This mutant would be 
required in validation experiments where eliminating oligomer formation is necessary. 
To help elucidate the details of hSSB1 oligomer – DNA interaction a mutant that has 
the potential to result in steric hindrance (e.g., R88GGG hSSB1(1-123) domain mutant) 
could also be utilised. 
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10.2 Isolation of different hSSB1 species for analysis  
 
Current analysis of oligomeric hSSB1 currently uses a solution containing an 
equilibrium of monomer, dimer, tetramer and higher oligomer. Once a stable oligomer 
species can be isolated further structural analysis can be attempted using 
crystallography in the absence/presence of DNA as well as NMR and SPR techniques. 
The formation and isolation of hSSB1 oligomers may be achieved through the trial of 
different cross-linkers or using an oxidative GSSG/GSH redox buffer system to test 
stable tetramer formation. 
 
10.3 hSSB1 interaction with other proteins within the BER pathway -hOGG1 
 
The localisation of hOGG1 to chromatin does not occur in the absence of hSSB1 (22). 
However, the details of the recruitment of hOGG1 to damaged DNA, remain undefined.  
 
During repair, the 8-oxoG base is extruded from the helical strand and inserted into the 
hOGG1 active site. Dipole-dipole electrostatic interactions (which allow for the quick 
scanning of DNA) as well as salt bridges and hydrogen bonds are formed between 
hOGG1 and DNA (74). The detection of 8-oxoG by hOGG1 is possible due to the 
presence of a proton on N7 that is capable of donating a hydrogen bond to the main 
chain carbonyl of Gly 42 (74). Once 8-oxoG is recognised, it is excised. This is 
achieved through nucleophilic displacement by the Ԑ- NH2 (amine) group of Lys 249 
(74, 75). Lys 249 forms a stable charged pair with Cys 253 which allows these residues 
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to orient opposite to the oxoG base and eliminate the 3’ phosphodiester bond at 8-
oxoG site via schiff-base chemistry.  
 
The interaction of hSSB1 and hOGG1 could be analysed through the application of 
SPR experiments to determine if the molecular state of hSSB1 has a role in interaction 
with hOGG1. Structural experiments with the aim to determine the exact interaction 
surface between hSSB1 and hOGG1 would also be crucial in increasing our 
understanding of the role of hSSB1 in the removal of oxidative damage through BER.  
 
10.4 Long-term outlook - drug development 
 
Oxidatively modified DNA is found in abundance in tumours (12). The presence of 8-
oxoG in the genome is a hallmark of cancer, with many studies indicating a correlation 
between the formation of 8-oxoG and carcinogenesis (11). The occurrence of 8-oxoG 
has also been linked to the pathogenesis of aging and several neurodegenerative 
diseases (13). Therapies used in the treatment of cancer generate DNA damage that 
is repaired by the proteins of the BER pathway (5). Repair of damaged DNA in 
cancerous cells after radio and chemo therapy allows the cancer to persist, therefore 
targeting BER proteins could be a way of decreasing resistance to the treatment (76). 
 
Some cancers have upregulated BER protein expression, including increased 
expression of hSSB1 (without which, hOGG1 recruitment does not occur and therefore 
BER cannot progress). In parallel with traditional therapies these cancers could 
potentially be targeted using small molecule inhibitors that target hSSB1, in order to 
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prevent DNA repair from occurring. Determining the structure and binding mode/s of 
the protein is a crucial step for effective future drug development, if this does prove to 
be a viable method in increasing the effectiveness of current therapies. 
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12. Appendices   
 
Appendix A – Constructs and oligonucleotides  
 
Table 12.1 hSSB1 constructs  
 
Table 12.2 dsDNA sequences  
  
Vector  Tag  Protein  Amino acid 
length  
Molecular  
weight (kDa)  
pI  Extinction 
coefficient 
M/cm (ε)  
pGEX6P  GST  hSSB1(1-123)  1-123  14  7.67  11585  
Name FWD 5’-3’ REV 5’-3’  
GC:GC 
mismatch 
GCGCATGCTACGCG CGCGTACGATGCGC 
GC:GC 
bubble 
GCCGCCGCCTATGCTATC 
CGCCGCCG 
CGGCGGCGGATACGATA 
GGCGGCGGC 
GCC end 
dsDNA  
GCCTATTATTATGCTATTAT 
TATCCG 
CGGATAATAATACGATAAT 
AATAGGC 
U:G 
mismatch  
CCAGGCTTAUCTCTTTATG CATAAAGAGGTAAGCCTGG 
8oxoG 
dsDNA  
CCAGGCTTA/8oxoG/CTCTTTATG CATAAAGAGCTAAGCCTGG 
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Table 12.3 ssDNA sequences  
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Name 5’-3’ 
5ToxoG TT(oxoG)TTT 
Oligo6T TTTTTT 
Oligo12T  TTTTTTTTTTTT 
3Aoligo6T  [Bt]AAATTTTTT 
3Aoligo12T [Bt]AAATTTTTTTTTTTT 
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Appendix B – Assigned 2D 1H-1H NOESY NMR spectra of 8-
oxoG dsDNA  
 
 
 
 
Assigned 2D 1H-1H NOESY NMR spectra for 8-oxoG dsDNA. Cross peaks (red) with assignments 
(black).  
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Appendix C – 1D 1H NMR spectra of dsDNA    
 
One dimensional (1D) 1H NMR spectra of dsDNA in the absence (black) and presence (blue) of 
non-reduced hSSB1(1-123). hSSB1 is able to unwind the DNA when sequences end in A:T base 
pairs (UG mismatch) but is unable to unwind the DNA when sequences end in G:C base pairs 
(GC: GC bubble and GC: GC mismatch). G:C terminus in sequence in indicated in red text, A:T 
terminus indicated in yellow text.  
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Appendix D – 2D 1H-15N HSQC NMR data  
 
Table 12.4 Weighted chemical shift changes for hSSB1(1-123) binding to ssDNA  
 Weighted chemical shift  change (calculated as in (44) 
Assignment 
(hSSB1 
residue 
number) 
reduced, 
oligo6T 
non-
reduced, 
oligo6T 
non-
reduced, 
5ToxoG 
reduced, 
oligo12T 
non 
reduced, 
oligo12T 
1 0 0.00609 0.00753 0.01108 0.01199 
2 0.0011 0.00696 0.00601 0.01183 0.01378 
3 0.00262 0.01342 0.0072 0.00515 0.00759 
4 0.00209 0.00699 0.00724 0.01301 0.01747 
5 0.01944 0.0322 0.02978 0.06129 0.08342 
6 0.00613 0.00807 0.00408 0.01973 0.02343 
7 0.02839 0.03619 0.02606 0.05289 0.04627 
8 0.0176 0.02097 0.02999 0.03844 0.03695 
9 0.01463 0.02641 0.02223 0.02701 0.02849 
10 0.0063 0.00508 0.01379 0.01128 0.00827 
11 0.01948 0.02016 0.03365 0.03689 0.04079 
13 0.04526 0.07211 0.09218 0.09426 0.0999 
14 0.01605 0.0224 0.02568 0.02321 0.024 
15 0.04344 0.05156 0.0465 0.09738 0.0989 
16 0.06603 0.11425 0.11902 0.22035 0.24606 
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17 0.01669 0.02398 0.05614 0.06626 0.07049 
18 0.0131 0.01001 0.00407 0.04802 0.04819 
19 0.03514 0.04323 0.032 0.12438 0.11996 
20 0.1043 0.07761 0.06444 0.01881 0.02727 
21 0.0122 0.02199 0.01328 0.02399 0.02691 
22 0.01313 0.0081 0.01698 0.01 0.01256 
23 0.00644 0.01534 0.01171 0.05788 0.05222 
24 0.03035 0.04334 0.03902 0.06335 0.06629 
25 0.03846 0.04193 0.03837 0.05421 0.06073 
26 0.03606 0.045 0.034 0.14205 0.149 
27 0.0818 0.10404 0.09621 0.12746 0.12993 
28 0.06929 0.09749 0.08482 0.057 0.06498 
29 0.03446 0.04633 0.03202 0.28183 0.28446 
30 0.14818 0.19727 0.23326 0.22082 0.21467 
31 0.1812 0.22688 0.23746 0.0266 0.03414 
32 0.00171 0.00566 0.03795 0.05227 0.06073 
33 -- -- -- 0.12218 0.12943 
34 0.03335 0.05358 0.06634 0.08522 0.09302 
35 0.06627 0.09934 0.09909 0.11935 0.12131 
36 0.04115 0.05917 0.07253 0.19955 0.209 
37 0.09781 0.08422 0.08511 0.16351 0.15706 
38 0.12231 0.15623 0.16092 0.04268 0.03799 
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39 0.18533 0.23406 0.24099 0.06101 0.06066 
40 0.0708 0.12397 0.0874 0.10251 0.11016 
41 0.0273 0.03258 0.03739 0.01505 0.0147 
42 0.03984 0.05341 0.04595 0.03366 0.03406 
43 0.06249 0.08279 0.07809 0.01968 0.02088 
44 0.01143 0.01678 0.01628 0.0148 0.0213 
45 0.0232 0.02386 0.02273 0.00699 0.00532 
46 0.00967 0.016 0.01205 0.0011 0.00101 
47 0.01089 0.01329 0.01375 0.05001 0.06144 
48 0.00197 0.01113 0.0037 0.06142 0.0587 
49 0.00462 0.00546 0.00243 0.06875 0.06468 
50 0.03216 0.04955 0.04212 0.01801 0.38501 
51 0.04014 0.05018 0.04457 0.28932 0.01451 
52 0.04548 0.0619 0.03476 0.02102 0.30057 
53 0.22975 0.29313 0.3101 0.09874 0.03214 
54 0.00557 0.003 0.02015 0.22317 0.09808 
55 0.25532 0.33751 0.37745 0.0867 0.36126 
56 0.18061 0.21552 0.2434 0.28396 0.22717 
57 0.01021 0.02273 0.01067 0.07469 0.10291 
58 0.06287 0.08096 0.06715 0.0094 0.28816 
59 0.20294 0.27567 0.29934 0.0097 0.0677 
60 0.13595 0.16733 0.19371 0.02716 0.00916 
 82 
  
61 0.05006 0.08497 0.06263 0.06856 0.00951 
62 0.18061 0.22274 0.25582 0.01416 0.02389 
63 0.04644 0.06242 0.04407 0.03938 0.07367 
65 0.00603 0.01007 0.00403 0.07599 0.02408 
66 0.0047 0.01179 0.00354 0.11479 0.04698 
67 0.01856 0.02355 0.01472 0.00443 0.08515 
68 0.04658 0.06102 0.04857 0.06618 0.13791 
69 0.01216 0.02446 0.01846 0.08374 0.10756 
70 0.02048 0.04064 0.04104 0.17679 0.01951 
71 0.03562 0.06485 0.05132 0.23843 0.06594 
72 0.04265 0.08131 0.08621 0.15529 0.0818 
73 0.03237 0.05623 0.01657 0.07312 0.18156 
74 0.0164 0.0295 0.06047 0.12763 0.2411 
75 0.04103 0.04459 0.05429 0.1362 0.12909 
76 0.04839 0.05128 0.06736 0.1246 0.089 
77 0.10874 0.13436 0.08663 0.08846 0.06706 
78 0.13397 0.17332 0.17598 0.21976 0.13032 
79 0.10361 0.1087 0.11501 0.32786 0.14002 
80 0.04001 0.05554 0.03992 0.1844 0.11506 
81 0.04963 0.061 0.06 0.107 0.36834 
82 0.0701 0.08415 0.12072 0.01324 0.43023 
83 0.07374 0.10384 0.13442 0.02532 0.40593 
 83 
  
84 0.0492 0.1109 0.07666 0.0437 0.36695 
85 0.23199 0.26739 0.30058 0.02662 0.19914 
86 -- -- 0.01374 0.01906 0.11827 
87 0.24693 0.33311 -- 0.00944 0.01549 
88 0.06942 0.09391 0.12772 3.08E-4 0.02569 
89 0.12333 0.18416 0.24886 0.05922 0.04234 
90 0.09091 0.13054 -- 0.0207 0.02349 
91 0.05823 0.07326 0.08235 0.0093 0.02767 
92 0.01193 0.01061 0.03404 0.0126 0.00878 
93 0.01517 0.02281 0.01234 0.02354 0.00147 
94 0.03303 0.04699 0.03667 0.009 0.06075 
95 0.01508 0.0346 0.02577 0.02199 0.02394 
96 0.0056 0.02347 0.01508 0.02537 0.00945 
97 0.00518 0.00202 0.00881 0.04107 0.01347 
98 0.00227 0.01237 0.00411 0.05436 0.01763 
99 0.06084 0.05995 0.04898 0.03265 0.00801 
100 0.00996 0.02466 0.01233 0.03384 0.02343 
101 0.00928 0.01451 0.00692 0.01805 0.03931 
102 0.00753 0.00765 0.00734 0.03241 0.04211 
103 0.00434 0.01493 0.01401 0.02599 0.05788 
104 0.00304 0.00826 0.00857 0.0167 0.03159 
107 0.01281 0.01275 0.01257 0.00441 0.03667 
 84 
  
108 0.016 0.02149 0.02301 0.00252 0.0219 
109 0.02024 0.03029 0.02031 0.00345 0.03772 
110 0.02595 0.03453 0.03668 0.00538 0.03138 
112 0.02221 0.01396 0.0164 -- 0.02154 
114 0.01905 0.01722 0.03957 -- 0.00713 
115 0.01679 0.01562 0.02156 -- 0.00407 
116 0.01686 0.02106 0.01866 -- 0.00319 
117 0.00814 0.02123 0.02003 -- 0.00796 
118 0.00411 0.01516 0.01212 0.01108 0.01199 
119 0.00197 0.01098 0.00441 0.01183 0.01378 
120 4.62E-4 0.00766 0.00579 0.00515 0.00759 
122 3.08E-4 0.00761 0.00401 0.01301 0.01747 
123 0.00252 0.0106 0.01056 0.06129 0.08342 
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Average chemical shift was calculated from the values listed in Table 12.4.  Residues 
with values above the average chemical shift are highlighted in red in the chemical shift 
profiles presented in Chapter 4 and Chapter 6. For all NMR experiments, a minimum 
four scans occurred when obtaining the values in Table 12.4 (n=4).   
 
Table 12.5 Mean chemical shifts for hSSB1 binding to ssDNA  
 Mean Standard Deviation SE of mean 
reduced, oligo6T 0.04663 0.00536 0 
non-reduced, 
oligo6T 
0.06384 0.07409 0.00694 
non-reduced, 
5ToxoG 
0.06194 0.07778 0.00243 
non-reduced, 
oligo12T 
0.07005 0.07348 0.00714 
non-reduced, 
oligo12T 
0.08648 0.09852 0.00935 
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Appendix E – Examplar protein gel   
  
 
 
 
SDS-PAGE gel. Samples from the purification of reduced 15N labelled hSSB1(1-123) (lanes 
labelled above) run on a NuPAGE Bis-Tris Mini gradient gel (4-20%). 
 
